Savaria Corporation (“Savaria”) (TSX: SIS), one of the global
leaders in the accessibility industry, is pleased to announce its
results for fiscal 2024.
Highlights – Fiscal 2024 compared
to 2023
- Revenue was $867.8M, up $30.8M or
3.7%, mainly due to organic growth of 3.7% and a positive foreign
exchange impact of 1.4%, partially offset by the divestitures of
Van-Action, Freedom Motors and the operations in Norway, net of the
acquisition of Matot.
- Accessibility organic growth stood at 3.4%, including growth of
8.4% coming from North America and partially offset by a
contraction of 2.5% in Europe.
- Patient Care organic revenue increased by 4.5%.
- Gross profit was $321.7M, up $35.7M or
12.5%, representing 37.1% of revenue, an increase of 290 bps
compared to 34.2% in 2023.
- Operating income was $84.1M, up $12.0M
or 16.6%, representing 9.7% of revenue compared to 8.6% in
2023.
- Adjusted EBITDA* was $161.2M, up
$31.2M or 24.0%, representing $2.25 per share, up $0.30.
- Adjusted EBITDA margin* stood at 18.6%
up 310 bps compared to 15.5% in 2023.
- Accessibility adjusted EBITDA margin reached 19.8%.
- Patient Care adjusted EBITDA margin stood at 19.1%.
- Net earnings were $48.5M or $0.68 per
share on a diluted basis, compared to $37.8M or $0.57 per share in
2023.
- The ratio of net debt to adjusted
EBITDA* stood at 1.63 in comparison to 2.07 as at December 31,
2023.
- Available funds* of $242.8M to support
working capital, investments and growth opportunities.
|
Q4 |
YTD |
in thousands of dollars, except per-share amounts |
2024 |
2023 |
Change |
2024 |
2023 |
Change |
Revenue |
$ |
223,340 |
|
$ |
216,839 |
|
|
3.0 |
% |
$ |
867,762 |
|
$ |
836,954 |
|
|
3.7 |
% |
Gross profit |
$ |
84,224 |
|
$ |
74,322 |
|
|
13.3 |
% |
$ |
321,712 |
|
$ |
286,020 |
|
|
12.5 |
% |
% of revenue |
|
37.7 |
% |
|
34.3 |
% |
|
340 |
bps |
|
37.1 |
% |
|
34.2 |
% |
|
290 |
bps |
Operating income |
$ |
21,772 |
|
$ |
19,843 |
|
|
9.7 |
% |
$ |
84,137 |
|
$ |
72,150 |
|
|
16.6 |
% |
Net earnings |
$ |
14,333 |
|
$ |
10,959 |
|
|
30.8 |
% |
$ |
48,510 |
|
$ |
37,841 |
|
|
28.2 |
% |
Diluted net earnings per share |
$ |
0.20 |
|
$ |
0.16 |
|
|
25.0 |
% |
$ |
0.68 |
|
$ |
0.57 |
|
|
19.3 |
% |
Adjusted net earnings* |
$ |
19,269 |
|
$ |
12,848 |
|
|
50.0 |
% |
$ |
64,795 |
|
$ |
42,909 |
|
|
51.0 |
% |
Adjusted net earnings per share* |
$ |
0.26 |
|
$ |
0.19 |
|
|
36.8 |
% |
$ |
0.90 |
|
$ |
0.65 |
|
|
38.5 |
% |
Adjusted EBITDA* |
$ |
42,867 |
|
$ |
35,105 |
|
|
22.1 |
% |
$ |
161,230 |
|
$ |
130,075 |
|
|
24.0 |
% |
Adjusted EBITDA per share* |
$ |
0.59 |
|
$ |
0.49 |
|
|
20.4 |
% |
$ |
2.25 |
|
$ |
1.95 |
|
|
15.4 |
% |
% of revenue |
|
19.2 |
% |
|
16.2 |
% |
|
300 |
bps |
|
18.6 |
% |
|
15.5 |
% |
|
310 |
bps |
*Non-IFRS measures are described and reconciled in
sections 3, 6 and 8 of the MD&A.
Words from the Executive Chairman and from
the President & CEO “Our record-breaking year finished
with an adjusted EBITDA of $161.2M, a 24% improvement over 2023,
largely attributable to our Savaria One program that successfully
achieved cost improvements across the business. With a
net-debt-to-adjusted-EBITDA ratio now at 1.6, and $243 million of
available funds, we have the flexibility for acquisitions or
investments to adapt to economic uncertainties. I am extremely
pleased and proud of our achievements in 2024,” said Marcel
Bourassa, Executive Chairman.
“In 2024, we saw 8% revenue growth in North
America in Accessibility as well as a significant increase in
adjusted EBITDA margin in Europe in Accessibility. Our Patient Care
segment finished the year with its best-ever sales quarter with a
23.1% adjusted EBITDA margin. In 2025, Savaria One will focus on
new growth opportunities. We are currently launching a new
through-the-floor home lift globally: the Savaria Luma. This
beautiful 2-stop lift is an ideal product for the aging population
looking to skip the stairs – another offering in the case they may
not want a stairlift.
“With our many Savaria One initiatives positively
impacting procurement, production and overall efficiencies, we have
built an even stronger foundation for our future growth. In spite
of pressure from trade measures, we have confidence in our agility
to overcome future challenges,” said Sébastien Bourassa, President
and Chief Executive Officer.
Fourth Quarter Results - Q4 2024
compared to Q4 2023
REVENUE
Revenue reached $223.3M, up $6.5M or 3.0%. The
increase was mainly due to organic growth of 0.9% and a positive
foreign exchange impact of 2.1%. The revenue contribution from the
acquisition of Matot was fully offset by the divestitures of
Van-Action and Freedom Motors.
- Accessibility segment (76% of Q4-24 revenue):
Revenue was $170.3M, a decrease of $3.4M or 1.9%. Organic
contraction was 4.0%.
- Patient Care segment (24% of Q4-24 revenue):
Revenue was $53.0M, an increase of $9.9M or 22.9%. Organically,
revenue increased by 20.6%.
OPERATING INCOME
Operating income was $21.8M, up $1.9M or 9.7%,
representing an operating margin of 9.7% compared to 9.2% in Q4
2023. The increase was mainly attributable to the contribution from
additional revenue and higher gross margins while partially offset
by increased strategic initiatives expenses.
ADJUSTED EBITDA
Adjusted EBITDA and adjusted EBITDA margin stood
at $42.9M and 19.2%, respectively, compared to $35.1M and 16.2% for
Q4 2023.
- Accessibility segment: Adjusted EBITDA and
adjusted EBITDA margin stood at $33.3M and 19.6%, respectively,
compared to $28.7M and 16.5% for Q4 2023.
- Patient Care segment: Adjusted EBITDA and
adjusted EBITDA margin stood at $12.2M and 23.1%, respectively,
compared to $7.9M and 18.3% for Q4 2023.
Twelve-Month Results - YTD 2024 compared
to YTD 2023
REVENUE
The Corporation generated revenue of $867.8M, up
$30.8M or 3.7%. The increase is mainly due to organic growth of
3.7% and a positive foreign exchange impact of 1.4%. The growth was
partially offset by the aforementioned divestitures, as well as the
divestiture of the operations in Norway in 2023, net of the
acquisition of Matot.
OPERATING INCOME
Operating income was $84.1M, up $12.0M or 16.6%,
representing an operating margin of 9.7% compared to 8.6% in
2023.
ADJUSTED EBITDA
Adjusted EBITDA and adjusted EBITDA margin stood
at $161.2M and 18.6%, respectively, compared to $130.1M and 15.5%
in 2023.
LIQUIDITY AND CAPITAL
RESOURCES
Savaria generated $120.1M of cash from operations
which was primarily used to invest in capital projects, a business
acquisition, repay debt and pay interest and dividends.
As at December 31, 2024, the Corporation had
a net debt position of $262.7M and a ratio of net debt to adjusted
EBITDA of 1.63 compared to 2.07 as of December 31, 2023.
Outlook
Savaria’s fiscal 2025 forecast projects revenue of
approximately $925M, with an adjusted EBITDA margin between 17% and
20%. We anticipate revenue growth of 5-8%, driven by volume and
price increases, new product launches, and favorable foreign
exchange effects across the Accessibility and Patient Care
segments. However, given the current macro environment and
potential tariff impacts, we have tempered our growth
expectations.
Despite these geopolitical uncertainties, the
completion of Savaria One positions us well to sustain
profitability. Structural improvements have enhanced production
capacity, increased operational efficiencies, and generated
meaningful cost savings through streamlined procurement.
As one of the global leaders in the accessibility
industry with extensive operations in Canada and the United States,
Savaria is assessing its supply chain and evaluating strategies to
optimize its North American manufacturing footprint. These efforts
aim to maintain competitiveness and ensure continued service for
our valued dealer partners.
The above-mentioned outlook is a “forward-looking
statement” within the meaning of the securities laws of Canada and
subject to the Corporation’s disclosure statement.
Environmental, Social and Governance
(“ESG”) Values
As a global leader within the accessibility
industry, Savaria is committed to minimizing its environmental
footprint and upholding the highest social and governance
standards. We believe that promoting environmentally and socially
responsible behaviour across our organization is key to achieving
sustainable growth and long-term value creation.
By delivering products and solutions that promote
accessibility, health, and wellness, improving operational
efficiencies and resource usage, and engaging our employees and
stakeholders, we’ll create a stronger, more resilient business that
will continue to be an industry leader while delivering positive
social change.
We recognize this work requires long-term vision,
planning, and collaboration, yet also must be grounded in clear
actions and an ongoing commitment to transparency.
Savaria is working towards the publication of its
2024 ESG report, which will provide additional sustainability
related disclosures and an update on the Company's ongoing ESG
strategy and initiatives. Until then, Savaria's 2023 ESG report can
be found under the investor relations section of our website at
savaria.com.
Savaria Corporation (savaria.com)
is a global leader in the accessibility industry. It provides
accessibility solutions for the physically challenged to increase
their comfort, their mobility and their independence. Its product
line is one of the most comprehensive on the market. Savaria
designs, manufactures, distributes and installs accessibility
equipment, such as elevators for home and commercial use,
stairlifts for straight and curved stairs, vertical and inclined
wheelchair lifts and dumbwaiters. In addition, Savaria manufactures
and markets a comprehensive selection of pressure management
products, medical beds, as well as an extensive line of medical
equipment and solutions for the safe movement of patients, such as
transfer, lifting and repositioning aids. The Corporation operates
a sales network of dealers worldwide and direct sales offices in
North America, Europe (UK, Netherlands, Switzerland, Italy,
Germany, Poland and Czech Republic) and Australia. Savaria employs
approximately 2,500 people globally and its plants are located
across Canada, the United States, Mexico, Europe and China.
Compliance with International Financial
Reporting Standards (“IFRS”)
The information appearing in this press release
has been prepared in accordance with IFRS. However, Savaria uses
EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted EBITDA
per share, adjusted net earnings, adjusted net earnings per share,
available funds, net debt and ratio of net debt to adjusted EBITDA
for analysis purposes to measure its financial performance. These
measures have no standardized definitions in accordance with IFRS
and are therefore regarded as non-IFRS measures. These measures may
therefore not be comparable to similar measures reported by other
companies. Additional details for these non-IFRS measures can be
found in sections 3, 6 and 8 of Savaria’s MD&A, which is posted
on Savaria’s website at savaria.com, and filed with SEDAR+ at
sedarplus.ca. Reconciliation of adjusted net earnings and adjusted
EBITDA with net earnings is presented in the section below.
Forward-Looking Statements
This press release includes certain statements
that are “forward-looking statements” within the meaning of the
securities laws of Canada. Any statement in this press release that
is not a statement of historical fact may be deemed to be a
forward-looking statement. When used in this press release, the
words “believe”, “could”, “should”, “intend”, “expect”, “estimate”,
“assume” and other similar expressions are generally intended to
identify forward-looking statements. It is important to know that
the forward-looking statements in this document describe the
Corporation’s expectations as at the date hereof, which are not
guarantees of future performance of Savaria or its industry, and
involve known and unknown risks and uncertainties that may cause
Savaria’s or the industry’s outlook, actual results or performance
to be materially different from any future results or performance
expressed or implied by such statements. The Corporation’s actual
results could be materially different from its expectations if
known or unknown risks affect its business, or if its estimates or
assumptions turn out to be inaccurate.
A change affecting an assumption can also have an
impact on other interrelated assumptions, which could increase or
diminish the effect of the change. As a result, the Corporation
cannot guarantee that any forward-looking statement will
materialize and, accordingly, the reader is cautioned not to place
undue reliance on these forward-looking statements. Forward-looking
statements do not take into account the effect that transactions or
special items announced or occurring after the statements are made
may have on the Corporation’s business. For example, they do not
include the effect of sales of assets, monetizations, mergers,
acquisitions, other business combinations or transactions, asset
write-downs or other charges announced or occurring after
forward-looking statements are made.
Unless otherwise required by applicable securities
laws, Savaria disclaims any intention or obligation to update or
revise the forward-looking statements, whether as a result of new
information, future events or otherwise. The foregoing risks and
uncertainties include the risks set forth under “Risks and
Uncertainties” in Savaria’s latest Annual MD&A as well as other
risks detailed from time to time in reports filed by Savaria with
securities regulators in Canada.
Results webcast and conference call on
March 6, 2025, at 8:30 a.m. (EST)
Savaria will host a conference call on Thursday,
March 6th at 8:30 a.m. Eastern Standard Time with financial
analysts to discuss results of the period ended December 31,
2024. Investors and members of the media are invited to participate
on a listen-only basis.
Conference call access: To
register:
https://register.vevent.com/register/BI4b09594fce5745358691b26898deb28d
Webcast (en): https://edge.media-server.com/mmc/p/j7mdr24h
Link to the replay of the webcast will be
available on the Corporation’s website at savaria.com.
For further information: |
|
|
Sébastien Bourassa President and Chief Executive Officer
sb@savaria.com 1.800.661.5112 |
Stephen Reitknecht, CPA Chief Financial Officer
sreitknecht@savaria.com 1.800.661.5112, ext. 3370 |
facebook.com/savariabettermobilitytwitter.com/Mobilityforlifewww.savaria.com |
|
|
|
Reconciliation of adjusted net earnings and
adjusted EBITDA with net earnings is provided below. Complete
financial statements and the management’s report for fiscal 2024
will be available shortly on Savaria’s website and on SEDAR+
sedarplus.ca.
Reconciliation of adjusted net earnings
and adjusted EBITDA with net earnings
|
Q4 |
YTD |
in thousands of dollars, except per-share amounts |
2024 |
2023 |
2024 |
2023 |
Net earnings |
$ |
14,333 |
|
$ |
10,959 |
|
$ |
48,510 |
|
$ |
37,841 |
|
Strategic initiatives expenses |
|
5,520 |
|
|
2,018 |
|
|
21,579 |
|
|
3,148 |
|
Other expenses |
|
949 |
|
|
522 |
|
|
569 |
|
|
3,679 |
|
Income tax related to strategic initiatives and other expenses |
|
(1,533 |
) |
|
(651 |
) |
|
(5,863 |
) |
|
(1,759 |
) |
Adjusted net earnings* |
$ |
19,269 |
|
$ |
12,848 |
|
$ |
64,795 |
|
$ |
42,909 |
|
Adjusted net earnings per share* |
$ |
0.26 |
|
$ |
0.19 |
|
$ |
0.90 |
|
$ |
0.65 |
|
Income tax related to strategic initiatives and other expenses |
|
1,533 |
|
|
651 |
|
|
5,863 |
|
|
1,759 |
|
Income tax expense |
|
5,033 |
|
|
4,103 |
|
|
17,155 |
|
|
12,474 |
|
Depreciation of fixed assets |
|
2,510 |
|
|
2,197 |
|
|
9,368 |
|
|
8,461 |
|
Depreciation of right-of-use assets |
|
3,194 |
|
|
2,611 |
|
|
11,690 |
|
|
10,061 |
|
Amortization of intangible assets |
|
8,205 |
|
|
7,511 |
|
|
31,131 |
|
|
30,610 |
|
Net finance costs |
|
2,406 |
|
|
4,781 |
|
|
18,472 |
|
|
21,835 |
|
Stock-based compensation |
|
717 |
|
|
403 |
|
|
2,756 |
|
|
1,966 |
|
Adjusted EBITDA* |
$ |
42,867 |
|
$ |
35,105 |
|
$ |
161,230 |
|
$ |
130,075 |
|
Adjusted EBITDA per share* |
$ |
0.59 |
|
$ |
0.49 |
|
$ |
2.25 |
|
$ |
1.95 |
|
Diluted weighted average number of shares |
|
72,357,117 |
|
|
71,031,225 |
|
|
71,651,011 |
|
|
66,476,434 |
|
*Non-IFRS measures are described and reconciled in
sections 3, 6 and 8 of the MD&A.
Grafico Azioni Savaria (TSX:SIS)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Savaria (TSX:SIS)
Storico
Da Mar 2024 a Mar 2025